Foxtron Vehicle Technologies Co., Ltd. — Investor Relations & Filings
Foxtron Vehicle Technologies Co., Ltd. is a joint venture established in 2020 by Hon Hai Technology Group (Foxconn) and Yulon Group. The company specializes in the research, development, and design of electric vehicles (EVs), integrating global ICT resources with decades of automotive manufacturing expertise. Foxtron provides comprehensive solutions including open hardware and software platforms, complete vehicle design, and key component supply chain management. Its core mission is to accelerate electric mobility through rational and precise design philosophies. The company offers integrated services ranging from initial concept and system validation to full-scale production. By utilizing an open-platform approach, Foxtron aims to shorten development cycles and reduce costs for global partners, positioning itself as a pivotal provider of new energy vehicle technologies and integrated vehicle design services.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 115年04月內部人持股異動(事後) | 2026-05-04 | Chinese | |
| 115年04月董事會成員及持股 | 2026-05-04 | Chinese | |
| 公告本公司提報民國115年第1季合併財務報告之 董事會預計召開日期為115年05月11日 | 2026-05-03 | Chinese | |
| 115年年報及股東會資料 — 2026_2258_20260522F17.pdf | 2026-04-30 | Chinese | |
| 115年年報及股東會資料 — 2025_2258_20260522FE4.pdf | 2026-04-30 | English | |
| 115年年報及股東會資料 — 2025_2258_20260522F04.pdf | 2026-04-30 | Chinese |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 40766874 | 115年04月內部人持股異動(事後) | 2026-05-04 | Chinese | ||
| 40766867 | 115年04月董事會成員及持股 | 2026-05-04 | Chinese | ||
| 40380612 | 公告本公司提報民國115年第1季合併財務報告之 董事會預計召開日期為115年05月11日 | 2026-05-03 | Chinese | ||
| 39933582 | 115年年報及股東會資料 — 2026_2258_20260522F17.pdf | 2026-04-30 | Chinese | ||
| 39933561 | 115年年報及股東會資料 — 2025_2258_20260522FE4.pdf | 2026-04-30 | English | ||
| 39933524 | 115年年報及股東會資料 — 2025_2258_20260522F04.pdf | 2026-04-30 | Chinese | ||
| 37799074 | 114年第4季財務報告書 — 202504_2258_AIC.pdf | 2026-04-28 | English | ||
| 37798984 | 114年第4季財務報告書 — 202504_2258_AIA.pdf | 2026-04-28 | English | ||
| 35209125 | 115年年報及股東會資料 — 2026_2258_20260522FE2.pdf | 2026-04-22 | Chinese | ||
| 34721596 | 115年年報及股東會資料 — 2026_2258_20260522F13.pdf | 2026-04-21 | Chinese | ||
| 34721524 | 115年年報及股東會資料 — 2026_2258_20260522F02.pdf | 2026-04-21 | Chinese | ||
| 34721319 | 115年年報及股東會資料 — 2026_2258_20260522FE1.pdf | 2026-04-21 | English | ||
| 34721291 | 115年年報及股東會資料 — 2026_2258_20260522F01.pdf | 2026-04-21 | Chinese | ||
| 33602506 | 115年3月背書保證與資金貸與 | 2026-04-05 | Chinese | ||
| 33602504 | 115年3月營業收入 | 2026-04-05 | Chinese | ||
Market data
Market data not available
Price history
Peer group · Research and experimental development on natural sciences and engineering
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Alteogen Inc.
Biopharmaceutical firm developing biologics with proprietar…
|
196170 | KR | Professional, scientific and te… |
|
ALTERITY THERAPEUTICS LIMITED
Clinical-stage developer of disease-modifying therapies for…
|
ATH | AU | Professional, scientific and te… |
|
AlzeCure Pharma
Develops therapies for severe diseases, focusing on Alzheim…
|
ALZCUR | SE | Professional, scientific and te… |
|
AMPLIA THERAPEUTICS LIMITED
Clinical-stage developer of FAK inhibitors for solid tumors…
|
ATX | AU | Professional, scientific and te… |
|
ANAPTYSBIO, INC
Clinical-stage biotech developing immunology therapeutics f…
|
ANAB | US | Professional, scientific and te… |
|
ANATARA LIFESCIENCES LTD
Develops non-antibiotic gastrointestinal health solutions f…
|
ANR | AU | Professional, scientific and te… |
|
AngioLab, Inc.
Develops angiogenesis inhibitors for pharmaceuticals and he…
|
251280 | KR | Professional, scientific and te… |
|
Anhui Wanbang Pharmaceutical Technology Co.,Ltd.
Pharmaceutical CRO specializing in clinical trials, BE stud…
|
301520 | CN | Professional, scientific and te… |
|
Anixa Biosciences Inc
A clinical-stage biotech developing therapies and vaccines …
|
ANIX | US | Professional, scientific and te… |
|
Annovis Bio, Inc.
A clinical-stage drug platform company developing therapies…
|
ANVS | US | Professional, scientific and te… |
Foxtron Vehicle Technologies Co., Ltd. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/51996/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=51996 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=51996 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=51996 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 51996}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Foxtron Vehicle Technologies Co., Ltd. (id: 51996)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.